ECALTA subst sèche 100 mg flac
7680583250035
CH-58325
J02AX06
08.06.0.
Reimbursement limitations:
ECALTA3
Traitement des candidémies et des formes invasives de la candidose chez les patients âgés d'1 …
1 / 3
google
Details
- Product number
- 5832502
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: anidulafunginum 100 mg, fructosum, mannitolum, polysorbatum 80, acidum tartaricum, pro vitro.
Articles (1)
Ecalta 100 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 442.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2011
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 58325
- Drug name
- Ecalta, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULP
- ATC Code
- J02AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/09/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ECALTA subst sèche 100 mg flac
- Description (DE)
- ECALTA Trockensub 100 mg Durchstf
- Market launch
- 28/12/2010
- Narcotic (BTM)
- No
Available generics
Anidulafungin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680683570019
CHF 381.95
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
GTIN:
7680677560019
CHF 381.95
Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
GTIN:
7680675730018
CHF 381.95